本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pasithea Therapeutics Corp.

0.5300
-0.0100-1.85%
盤後0.53000.00000.00%17:25 EDT
成交量:14.11萬
成交額:7.50萬
市值:1,770.97萬
市盈率:-0.36
高:0.5515
開:0.5310
低:0.5202
收:0.5400
52周最高:2.06
52周最低:0.2810
股本:3,341.44萬
流通股本:1,020.20萬
量比:0.66
換手率:1.38%
股息:- -
股息率:- -
每股收益(TTM):-1.4820
每股收益(LYR):-2.9100
淨資產收益率:-65.49%
總資產收益率:-36.00%
市淨率:0.36
市盈率(LYR):-0.18

資料載入中...

2023/02/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

重要事件披露

8-K - Current report
2023/01/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

重要事件披露

8-K - Current report
2022/12/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/12

重要事件披露

8-K - Current report
2022/09/21

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/20

重要事件披露

8-K - Current report
2022/09/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/29

重要事件披露

8-K/A [Amend] - Current report
2022/08/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals